NPI | Name | Type | Address |
---|---|---|---|
PHARMD Wendy Covert |
Individual |
1515 Holcombe Blvd Houston, TX |
|
Magy Samir Eskander |
Individual |
8700 Beverly Blvd West Hollywood, CA |
|
PHARMD Zach Rivers |
Individual |
909 Fulton St Se Minneapolis, MN |
|
PHARMD Megan Mullalley |
Individual |
4393 S Riverboat Rd Taylorsville, UT |
|
Alexandra Erin Chambers |
Individual |
2946 E Banner Gateway Dr Gilbert, AZ |
|
Zakary Cerminara |
Individual |
825 Eastlake Ave E Seattle, WA |
|
PHARMD BCOP Adam E Skrypack |
Individual |
160 N Midland Ave Nyack, NY |
|
PHARMD Houry Leblebjian |
Individual |
450 Brookline Ave Boston, MA |
|
PHARMD Nilomi Nilesh Shah |
Individual |
3701 Broadway Oakland, CA |
|
PHARM.D. Monica Tadros |
Individual |
8900 N Kendall Dr Miami, FL |
|
PHARMD Leonette Olivia Kemp |
Individual |
8900 N Kendall Dr Miami, FL |
|
PHARMD Neelam Kishor Patel |
Individual |
1515 Holcombe Blvd Houston, TX |
|
DR. PHARMD Cole R Lightfoot |
Individual |
9200 W Wisconsin Ave Milwaukee, WI |
|
DR. PHARMD, CPP Ethan James Sebring |
Individual |
2131 S 17th St Wilmington, NC |
|
Sarah Dunaway |
Individual |
1400 Hal Greer Blvd Huntington, WV |
|
R.PH Jan Ellen Kover |
Individual |
2500 Metrohealth Dr Cleveland, OH |
|
PHARMD Peter Wu |
Individual |
1725 W Harrison St Chicago, IL |
|
PHARMD Tu Nguyen Doan Vuong |
Individual |
1500 Duarte Rd Duarte, CA |
|
PHARMD Christopher Lucas |
Individual |
1700 Coffee Rd Modesto, CA |
|
PHARMD Alyssa Donadio |
Individual |
8900 N Kendall Dr Miami, FL |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |